Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2182 | Low Dose Radiation Therapy (LD-RT) Wiki | 1.00 |
| drug4070 | Transfusion of standard Plasma. Wiki | 1.00 |
| drug4069 | Transfusion of SARS-CoV-2 Convalescent Plasma. Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D013577 | Syndrome NIH | 0.09 |
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This study is to analyse the efficacy of LD-RT for treatment of Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2).
Description: Ventilator free days (VFD)
Measure: Ventilator free days (VFD) Time: at day 15 after LD-RTDescription: Change in pulmonary function, measured as relative change (%) from baseline in oxygenation index (PaO2 / FiO2)
Measure: Change in pulmonary function, measured as relative change (%) from baseline in oxygenation index (PaO2 / FiO2) Time: at day 5, 10, 15, 28 after LD-RTDescription: Overall mortality
Measure: Overall mortality Time: at day 15 and 28 after LD-RTDescription: Change in levels of ferritin (ng/ml)
Measure: Change in levels of ferritin (ng/ml) Time: up to day 15 after LD-RTDescription: Change in levels of c-reactive protein (mg/l)
Measure: Change in levels of c-reactive protein (mg/l) Time: up to day 15 after LD-RTDescription: Change in levels of white blood cell counts (number of white blood cells per volume of blood)
Measure: Change in levels of white blood cell counts (number of white blood cells per volume of blood) Time: up to day 15 after LD-RTAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports